We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+124.18%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
+$628M
Cap. Flow
+$47.5M
Cap. Flow %
2.9%
Top 10 Hldgs %
56.65%
Holding
43
New
13
Increased
12
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$67.8M
2
EXAS
Exact Sciences
EXAS
+$51M
3
AXGN icon
Axogen
AXGN
+$44.1M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$37.4M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$34.7M

Top Sells

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$96.9M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$94.9M
3
GMED icon
Globus Medical
GMED
+$67.1M
4
VCEL icon
Vericel Corp
VCEL
+$35.5M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$29.1M

Sector Composition

Rank Sector Weight
1 Healthcare 93.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
26
Insulet
PODD
$11.8B
$26.7M 1.63%
155,800
– –
ADMA icon
27
ADMA Biologics
ADMA
$2.03B
$20.7M 1.26%
5,166,961
+51,975
+1% +$227K
STAA icon
28
STAAR Surgical
STAA
$1.21B
$15M 0.91%
425,800
-801,971
-65% -$26.5M
OVID icon
29
Ovid Therapeutics
OVID
$435M
$12M 0.73%
+2,888,888
New +$9.12M
KRYS icon
30
Krystal Biotech
KRYS
$9.25B
$11.3M 0.69%
203,788
-20,302
-9% -$996K
BEAT
31
DELISTED
BioTelemetry, Inc.
BEAT
$7.18M 0.44%
+155,000
New +$6.71M
FOLD
32
DELISTED
Amicus Therapeutics
FOLD
$4.95M 0.3%
+507,739
New +$4.65M
TPTX
33
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$4.44M 0.27%
+71,300
New +$3.39M
APLS
34
DELISTED
Apellis Pharmaceuticals
APLS
$4.13M 0.25%
+135,000
New +$3.74M
MOR
35
DELISTED
MorphoSys AG American Depositary Shares
MOR
$769K 0.05%
+21,561
New +$644K
AMRN
36
Amarin Corp
AMRN
$297M
– –
-319,513
Closed -$96.9M
ANIP icon
37
ANI Pharmaceuticals
ANIP
$1.82B
– –
-142,943
Closed -$10.4M
CPRX
38
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-17,875,655
Closed -$94.9M
GMED icon
39
Globus Medical
GMED
$11.1B
– –
-1,313,177
Closed -$67.1M
MBIO icon
40
Mustang Bio
MBIO
$4.37M
– –
-4,213
Closed -$10.3M
SVRA icon
41
Savara
SVRA
$1.09B
– –
-1,568,002
Closed -$4.16M
QTTB icon
42
Q32 Bio
QTTB
$451M
– –
-2,253
Closed -$734K
IMMU
43
DELISTED
Immunomedics Inc
IMMU
– –
-45,000
Closed -$597K
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Consonance Capital Management held 43 positions worth $1.64B, up 62% from $1.01B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Consonance Capital Management's Q4 2019 filing shows 13 new, 12 increased, 8 reduced and 8 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 604,604 shares worth $63.2M. The largest sale was Amarin Corp, an estimated $96.9M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 99% a quarter earlier.

  • Consonance Capital Management's largest Q4 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 604,604 shares worth $63.2M.
  • Consonance Capital Management added most to Aurinia Pharmaceuticals in Q4 2019, an estimated $37.4M increase.
  • Consonance Capital Management's biggest Q4 2019 reduction was Vericel Corp, cutting an estimated $35.5M.
  • Consonance Capital Management fully exited Amarin Corp in Q4 2019, selling an estimated $96.9M.
  • Consonance Capital Management's ten largest holdings make up 57% of its $1.64B portfolio in Q4 2019.
  • Consonance Capital Management opened 13 new positions and closed 8 in Q4 2019.
  • Consonance Capital Management's portfolio value rose 62% quarter-over-quarter to $1.64B.

Based on Consonance Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.